Publications by authors named "Lynnette T Kyokunda"
Article Synopsis
- Cervical cancer continues to be a significant public health challenge in Botswana, particularly among indigenous and marginalized groups, despite the introduction of a quadrivalent HPV vaccine and screening initiatives.
- A study involving 171 non-HPV vaccinated women aged 21 and older assessed the prevalence of high-risk HPV genotypes and cervical lesions through interviews, Pap smears, and HPV testing.
- The results revealed that 31% of participants were HIV positive, and 13.5% exhibited cervical dysplasia, with various atypical cell types identified, although no cases of high-grade lesions or cervical cancer were found.
Introduction: Cervical cancer, a malignancy caused by infection with oncogenic human papillomavirus, disproportionally affects women from low resource settings. Persistence of human papillomavirus infection may mediate an association between tobacco use and cervical cancer. In limited resource settings, women from indigenous communities are often marginalized and do not benefit from evidence-based interventions to prevent tobacco use or cervical cancer due to the limited reach of mainstream healthcare services to these communities.
View Article and Find Full Text PDFArticle Synopsis
- Pulmonary diseases in low- and middle-income countries vary widely based on factors like population, environmental conditions, and smoking habits.
- Effective assessment of lung diseases relies on skilled healthcare professionals and access to imaging, microbiology, and pathological diagnostics.
- Improving targeted research and interventions in lung cancer treatment is essential for better patient outcomes and to reduce the severity of the disease.
We report a fatal case of SARS-CoV-2 and coinfection in an infant, Botswana's first paediatric COVID-19-associated fatality. The patient, a 3-month-old HIV-unexposed boy, presented with fever and respiratory distress in the setting of failure to thrive. Both the patient and his mother tested positive for rifampin-sensitive (Xpert MTB/Rif) and SARS-CoV-2 (real time-PCR).
View Article and Find Full Text PDF